Skip to main content

Advertisement

SpringerLink
Log in

Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

New-onset diabetes after transplantation (NODAT) is a common complication in renal transplant (RT) patients. The clinical significance of pre-transplant HbA1c level remains unclear in RT patients. Thus, we investigated the predictive role of pre-transplant HbA1c levels for the NODAT diagnosed in 1 year after renal transplantation.

Methods

Two hundred and four RT patients older than 18 years were analyzed. NODAT diagnosis during the 1-year follow-up after RT was based on the 2003 modified criteria of the ADA. HbA1c level was measured at pre-transplantation period and every 3 months after RT.

Results

Mean age was 39.3 ± 10.7 (20–73) years and 36 % were female. Mean pre-transplant HbA1c level was 4.9 ± 0.5 % (4.0–6.4 %). Pre-transplant HbA1c level was positively correlated with age, pre-transplant body mass index (BMI) and cholesterol level. Fifty-four patients (25.9 %) developed NODAT and 33.8 % had impaired fasting blood glucose levels. Patients with NODAT were significantly older and had higher pre-transplant BMI and HbA1c than those without. Use of Tacrolimus was also higher in patients with NODAT. In stepwise logistic regression analysis, pre-transplant HbA1c level was an independent predictor for the development on NODAT (OR = 4.63, 95 % CI: 2.09–10.2, p < 0.001) together with age, Tacrolimus-based regimen and pre-transplant fasting blood glucose level.

Conclusions

Assessment of pre-transplant HbA1c levels may be a valuable tool for early diagnosis of NODAT in RT recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kasiske BL, Snyder JJ, Gilbertson D et al (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3(2):178–185

    Article  PubMed  Google Scholar 

  2. Demirci MS, Toz H, Yilmaz F et al (2010) Risk factors and consequences of post-transplant diabetes mellitus. Clin Transplant 24(5):170–177

    Article  Google Scholar 

  3. Woodward RS, Schnitzler MA, Baty J (2003) Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 3(5):590–598

    Article  PubMed  Google Scholar 

  4. Ojo AO (2006) Cardiovascular complications after renal transplantation and their prevention. Transplantation 82(5):603–611

    Article  PubMed  Google Scholar 

  5. Hjelmesaeth J, Hartmann A, Leivestad T et al (2006) The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 69(3):588–595

    Article  PubMed  CAS  Google Scholar 

  6. Cosio FG, Pesavento TE, Kim S et al (2002) Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 62(4):1440–1446

    Article  PubMed  Google Scholar 

  7. Cosio FG, Kudva Y, van der Velde M et al (2005) New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 67(6):2415–2421

    Article  PubMed  Google Scholar 

  8. Boudreaux JP, McHugh L, Canafax DM et al (1987) The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation 44(3):376–381

    Article  PubMed  CAS  Google Scholar 

  9. Sharif A, Baboolal K (2010) Risk factors for new-onset diabetes after kidney transplantation. Nat Rev Nephrol 6(7):415–423

    Article  PubMed  Google Scholar 

  10. Pham PT, Pham PM, Pham SV et al (2011) New onset diabetes after transplantation (NODAT): an overview. Diabetes Metab Syndr Obes 4:175–186

    Article  PubMed  Google Scholar 

  11. Dunn PJ, Cole RA, Soeldner JS et al (1979) Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance. Ann Intern Med 91(3):390–396

    PubMed  CAS  Google Scholar 

  12. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7):1327–1334

    Article  Google Scholar 

  13. Saudek CD, Herman WH, Sacks DB et al (2008) A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 93(7):2447–2453

    Article  PubMed  CAS  Google Scholar 

  14. Ginde AA, Cagliero E, Nathan DM et al (2008) Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population. J Gen Intern Med 23(9):1346–1353

    Article  PubMed  Google Scholar 

  15. Hoban R, Gielda B, Temkit M et al (2006) Utility of HbA1c in the detection of subclinical post renal transplant diabetes. Transplantation 81(3):379–383

    Article  PubMed  CAS  Google Scholar 

  16. Valderhaug TG, Jenssen T, Hartmann A et al (2009) Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation. Transplantation 88(3):429–434

    Article  PubMed  Google Scholar 

  17. The expert committee on the diagnosis and classification of diabetes mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26:5–20

    Article  Google Scholar 

  18. Danaei G, Finucane MM, Lu Y et al (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378(9785):31–40

    Article  PubMed  CAS  Google Scholar 

  19. Pirsch JD, Miller J, Deierhoi MH et al (1997) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 63(7):977–983

    Article  PubMed  CAS  Google Scholar 

  20. van Duijnhoven EM, Christiaans MH, Boots JM et al (2002) Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol 13(1):213–220

    PubMed  Google Scholar 

  21. Boots JM, van Duijnhoven EM, Christiaans MH et al (2002) Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 13(1):221–227

    PubMed  CAS  Google Scholar 

  22. Ishimura E, Okuno S, Kono K et al (2009) Glycemic control and survival of diabetic hemodialysis patients—importance of lower hemoglobin A1C levels. Diabetes Res Clin Pract 83(3):320–326

    Article  PubMed  CAS  Google Scholar 

  23. Perry RC, Shankar RR, Fineberg N et al (2001) HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with non-diagnostic levels of fasting plasma glucose. Diabetes Care 24(3):465–471

    Article  PubMed  CAS  Google Scholar 

  24. Kim KS, Kim SK, Lee YK et al (2008) Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects. Diabet Med 25(8):997–1000

    Article  PubMed  CAS  Google Scholar 

  25. Rigalleau V, Gin H (2005) Carbohydrate metabolism in uraemia. Curr Opin Clin Nutr Metab Care 8(4):463–469

    Article  PubMed  CAS  Google Scholar 

  26. Chen J, Muntner P, Hamm LL et al (2003) Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14(2):469–477

    Article  PubMed  CAS  Google Scholar 

  27. Shaw JE, Hodge AM, de Courten M et al (1999) Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 42(9):1050–1054

    Article  PubMed  CAS  Google Scholar 

  28. Hanefeld M, Fischer S, Julius U et al (1996) Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39(12):1577–1583

    Article  PubMed  CAS  Google Scholar 

  29. Monnier L, Lapinski H, Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26(3):881–885

    Article  PubMed  Google Scholar 

  30. Ramesh Prasad GV, Huang M, Bandukwala F et al (2009) Pre-transplantation glucose testing for predicting new-onset diabetes mellitus after renal transplantation. Clin Nephrol 71(2):140–146

    PubMed  CAS  Google Scholar 

  31. Nam JH, Mun JI, Kim SI et al (2001) Beta-cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus. Transplantation 71(10):1417–1423

    Article  PubMed  CAS  Google Scholar 

  32. Bergrem HA, Valderhaug TG, Hartmann A et al (2010) Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy. Clin J Am Soc Nephrol 5(4):616–622

    Article  PubMed  CAS  Google Scholar 

  33. Caillard S, Eprinchard L, Perin P et al (2011) Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test. Transplantation 91(7):757–764

    PubMed  CAS  Google Scholar 

  34. Peters AL, Davidson MB, Schriger DL et al (1996) A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels. JAMA 276(15):1246–1252

    Article  PubMed  CAS  Google Scholar 

  35. Dheir H, Ozkahya M, Kircelli F et al (2012) Glycosylated hemoglobin levels are associated with cardiovascular events in nondiabetic peritoneal dialysis patients. J Nephrol 25(1):107–112

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Nephrology, Ege University School of Medicine, 35100, Bornova, Izmir, Turkey

    Erhan Tatar, Fatih Kircelli, Meltem Sezis Demirci, Mehmet Nuri Turan, Ozkan Gungor, Gulay Asci, Mehmet Ozkahya, Ercan Ok & Huseyin Toz

  2. Division of General Surgery, Ege University School of Medicine, Izmir, Turkey

    Cuneyt Hoscoskun

Authors
  1. Erhan Tatar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatih Kircelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Meltem Sezis Demirci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehmet Nuri Turan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ozkan Gungor
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gulay Asci
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mehmet Ozkahya
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ercan Ok
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Cuneyt Hoscoskun
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Huseyin Toz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erhan Tatar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tatar, E., Kircelli, F., Demirci, M.S. et al. Pre-transplant HbA1c level as an early marker for new-onset diabetes after renal transplantation. Int Urol Nephrol 45, 251–258 (2013). https://doi.org/10.1007/s11255-012-0304-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-012-0304-z

Keywords

Search

Navigation